Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

7.320 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,099
Open 7.320
Bid (Size) 7.390 (2)
Ask (Size) 7.530 (5)
Prev. Close 7.320
Today's Range 7.320 - 7.320
52wk Range 3.810 - 23.86
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novavax Retail Traders Stay Bullish Ahead Of Q4 Print Even As RFK Jr's HHS Leadership Causes Ripples
Kennedy, a longtime vaccine skeptic, now oversees HHS decisions that could impact vaccine makers, making his leadership a wild card for Novavax. 
Via Stocktwits
Earnings Scheduled For February 27, 2025
Via Benzinga

Performance

YTD
-14.59%
-14.59%
1 Month
-21.46%
-21.46%
3 Month
-15.08%
-15.08%
6 Month
-34.23%
-34.23%
1 Year
+21.59%
+21.59%

More News

Read More
(NVAX) - Analyzing Novavax's Short Interest
Via Benzinga
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
Via Benzinga
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
Via Benzinga
Topics Government
Exposures Political
Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots
Via Investor's Business Daily
Exposures COVID-19
Looking Into Novavax's Recent Short Interest
Via Benzinga
Why Novavax (NVAX) Stock Is Falling
Via Benzinga
Peering Into Novavax's Recent Short Interest
Via Benzinga
Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads
Via Benzinga
Topics Government
Exposures Political
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
Via Benzinga
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Via Investor's Business Daily
Topics Government
Exposures Political
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing
Via Benzinga
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz
Via Stocktwits
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Via Investor's Business Daily
Why Novavax Stock Is Volatile This Week
Via Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Via Benzinga
Topics ETFs
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
Via Investor's Business Daily
Exposures COVID-19
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Via Benzinga
Why Novavax (NVAX) Stock Is Rising
Via Benzinga
Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
Via Talk Markets
Topics ETFs Stocks / Equities
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Via Benzinga
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors
Via The Motley Fool
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.